Fortis Healthcare Limited has announced its financial results for the quarter and year ended March 31, 2026. The company reported a significant increase in annual revenue to ₹912,784 lacs, with a consolidated net profit of ₹106,419 lacs. Additionally, the Board has recommended a final dividend of ₹1 per equity share for the fiscal year 2025-26, reflecting the company’s strong operational performance and commitment to delivering value to shareholders.
Consolidated Financial Performance
For the financial year ended March 31, 2026, Fortis Healthcare demonstrated strong growth across its operations. The company’s annual revenue from operations rose to ₹912,784 lacs, compared to ₹778,275 lacs in the previous year. The consolidated net profit for the year stood at ₹106,419 lacs, marking a substantial increase from ₹80,938 lacs in FY25.
For the quarter ended March 31, 2026, the company reported revenue of ₹236,467 lacs and a net profit of ₹27,119 lacs, maintaining a positive growth trajectory.
Dividend Declaration
The Board of Directors has recommended a final dividend of ₹1 per equity share (representing 10% of the face value of ₹10 each) for the financial year 2025-26. This dividend is subject to approval by the members at the upcoming Annual General Meeting and, if approved, will be disbursed within 30 days.
Segment Performance
The company maintains two primary reportable segments: Healthcare and Diagnostics. The Healthcare segment delivered a strong segment profit of ₹139,370 lacs for the year, while the Diagnostics segment contributed ₹24,185 lacs to the total segment profit before interest and tax.
Strategic Developments
During the fiscal year, Fortis Healthcare continued its strategic expansion, including the acquisition of TMI Healthcare Private Limited (which operates the 125-bedded People Tree Hospital in Bengaluru) for a total consideration of ₹43,386 lacs. Furthermore, the company has appointed M/s Jitender, Navneet & Co. as the Cost Auditor for the financial year 2026-27 and has approved a new Corporate Social Responsibility (CSR) policy.
Operational Highlights
The company continues to focus on long-term sustainability and operational efficiency. The Board has also granted 1,32,05,200 employee stock options (ESOP) under its newly approved 2026 Employee Stock Option Scheme, reinforcing its commitment to human capital and organizational growth.
Source: BSE
